{"id":3809,"date":"2026-09-24T09:13:37","date_gmt":"2026-09-24T08:13:37","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=3809"},"modified":"2026-09-24T10:10:29","modified_gmt":"2026-09-24T09:10:29","slug":"cphi-2026-milan-serum-free-media-vaccine-manufacturing","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/","title":{"rendered":"CPHI 2026 Milan \u2014 SeamlessBio"},"content":{"rendered":"<p><!--\nWORDPRESS BLOG POST \u2014 UPDATE (CelluPro + Festival of Biologics entfernt, Stand Hall 12 F75 erg\u00e4nzt)\nSlug: cphi-2026-milan-serum-free-media-vaccine-manufacturing  \u2190 bestehende URL behalten!\nSEO Title: CPHI 2026 Milan \u2014 SeamlessBio: Biological Raw Materials & Serum-Free Media\nMeta Description: SeamlessBio at CPHI Worldwide 2026 in Milan, Hall 12 F75. Serum-free media, FBS alternatives and biological supply chain solutions for CROs, ATMP and vaccine manufacturers.\nFocus Keyword: CPHI 2026 Milan serum-free media\nAdditional Keywords: CPHI Milan 2026, serum-free media vaccine production, FBS supply shortage 2026, biological supplier Europe, FBS alternatives ATMP, cell culture media GMP\nCategory: Events \u00b7 Cell Culture \u00b7 Bioprocessing\n--><br \/>\n<script type=\"application\/ld+json\">\n{\"@context\":\"https:\/\/schema.org\",\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/seamlessbio.de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blog\",\"item\":\"https:\/\/seamlessbio.de\/blog\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CPHI 2026 Milan \u2014 SeamlessBio at Hall 12, Stand F75\",\"item\":\"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/\"}]}\n<\/script><\/p>\n<style>\n.sb-bp{font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,sans-serif;max-width:780px;margin:0 auto;padding:0 0 60px;color:#202020;line-height:1.75}\n.sb-bp .lede{font-size:18px;font-weight:500;color:#3a4a50;border-left:4px solid #18b7b2;padding-left:20px;margin:0 0 32px;line-height:1.65}\n.sb-bp h2{font-size:24px;font-weight:800;margin:44px 0 14px;color:#111;padding-bottom:10px;border-bottom:2px solid #e2eceb}\n.sb-bp h3{font-size:18px;font-weight:700;margin:28px 0 10px;color:#18b7b2}\n.sb-bp p{margin:0 0 18px}\n.sb-bp ul,.sb-bp ol{margin:0 0 18px;padding-left:24px}\n.sb-bp li{margin-bottom:8px}\n.sb-bp table{width:100%;border-collapse:collapse;font-size:14px;margin:20px 0 28px;display:block;overflow-x:auto}\n.sb-bp th{background:#18b7b2;color:#fff;text-align:left;padding:10px 14px;font-weight:700;white-space:nowrap}\n.sb-bp td{padding:10px 14px;border-bottom:1px solid #e2eceb;vertical-align:top}\n.sb-bp tr:last-child td{border-bottom:none}\n.sb-bp td:first-child{font-weight:600;color:#111}\n.sb-bp a{color:#18b7b2;font-weight:600;text-decoration:none}\n.sb-bp strong{color:#111}\n.sb-bp .qa{background:#f1faf9;border-left:4px solid #18b7b2;border-radius:0 12px 12px 0;padding:18px 22px;margin:24px 0}\n.sb-bp .qa .q{font-weight:700;font-size:15px;color:#111;margin:0 0 6px}\n.sb-bp .qa .a{font-size:14px;margin:0}\n.sb-bp .box{background:#f1faf9;border-left:4px solid #18b7b2;border-radius:0 12px 12px 0;padding:18px 22px;margin:24px 0}\n.sb-bp .event-box{background:#fff;border:1px solid #d0ecea;border-radius:12px;padding:20px 24px;margin:20px 0;display:flex;gap:20px;align-items:flex-start}\n.sb-bp .event-box .date{background:#18b7b2;color:#fff;border-radius:8px;padding:10px 14px;text-align:center;min-width:60px;font-weight:800;font-size:13px;line-height:1.3;flex-shrink:0}\n.sb-bp .event-box .info h4{margin:0 0 4px;font-size:16px;font-weight:700;color:#111}\n.sb-bp .event-box .info p{margin:0;font-size:14px;color:#5b6b71}\n.sb-bp .cta{background:linear-gradient(135deg,#e4f6f5,#f4fbfb);border:1px solid rgba(24,183,178,.2);border-radius:16px;padding:28px;margin-top:44px;text-align:center}\n.sb-bp .cta h3{color:#111;margin:0 0 8px;font-size:20px}\n.sb-bp .cta p{color:#5b6b71;margin:0 0 16px}\n.sb-bp .cta-btns{display:flex;justify-content:center;gap:12px;flex-wrap:wrap}\n.sb-bp .btn{display:inline-block;background:#18b7b2;color:#fff!important;padding:10px 22px;border-radius:8px;font-weight:700;font-size:14px;text-decoration:none!important}\n.sb-bp .btn-o{display:inline-block;border:2px solid #18b7b2;color:#18b7b2!important;padding:8px 22px;border-radius:8px;font-weight:700;font-size:14px;text-decoration:none!important}\n<\/style>\n<div class=\"sb-bp\">\n<p class=\"lede\">SeamlessBio is at CPHI Worldwide 2026 in Milan \u2014 Hall 12, F75. If you are dealing with FBS supply pressure, evaluating serum-free alternatives, or looking to qualify a backup supplier for biological raw materials, come talk to us.<\/p>\n<h2>Where to Find Us at CPHI 2026<\/h2>\n<div class=\"event-box\">\n<div class=\"date\">OCT<br \/>6\u20138<\/div>\n<div class=\"info\">\n<h4>CPHI Worldwide 2026 \u2014 Milan, Italy<\/h4>\n<p>Fiera Milano \u00b7 <strong>Hall 12, Stand F75<\/strong> \u00b7 Pascal Zimmermann, SeamlessBio \u00b7 Available for meetings on FBS, Human Serum, serum-free media, DMPK kits and biological supply chain<\/p>\n<\/p><\/div>\n<\/div>\n<p>CPHI Worldwide is the largest pharma ingredients show in the world \u2014 over 60,000 attendees, 2,500+ exhibitors, and three days of concentrated industry access. If you are in Milan and working in biopharma manufacturing, procurement, or CRO services, find us at <strong>Hall 12, Stand F75<\/strong> to talk about your biological raw material needs.<\/p>\n<p><a href=\"https:\/\/seamlessbio.de\/contact\/\">Schedule a meeting in advance<\/a> via info@seamlessbio.de.<\/p>\n<h2>What Is Keeping Biopharma Procurement Teams Up at Night in 2026<\/h2>\n<p>The conversations we are having most often this year \u2014 at shows, with CROs, with ATMP manufacturers \u2014 come down to three core issues:<\/p>\n<h3>1. FBS Supply Is Not Getting Better<\/h3>\n<p>The US cattle herd hit a 75-year low at the start of 2026. FBS is a byproduct of beef processing \u2014 and when fewer animals go to slaughter, less serum is collected, regardless of what the market needs. Supply constraints will persist through 2028\u20132029 at minimum. For any organisation that depends on FBS in a validated GMP process, the question is no longer whether to have a contingency plan \u2014 it is how good that plan is.<\/p>\n<h3>2. Regulatory Pressure on Animal-Derived Materials Is Increasing<\/h3>\n<p>EMA, FDA and ICH guidelines are moving in a clear direction: manufacturers of products intended for human use are expected to justify the use of animal-derived materials and to have a defined path toward elimination where technically feasible. For ATMP manufacturers and vaccine producers in particular, this pressure is already shaping procurement decisions today.<\/p>\n<h3>3. Serum-Free Media Has Matured \u2014 But Transition Takes Planning<\/h3>\n<p>Chemically defined, serum-free media for CHO cells, HEK293, Vero, MDCK and T-cell expansion now perform comparably to serum-supplemented alternatives at commercial scale. The barrier is not biology \u2014 it is process development investment and change management. For organisations planning new manufacturing campaigns or facility expansions, now is the right time to evaluate the transition.<\/p>\n<h2>What SeamlessBio Brings to the Table<\/h2>\n<p>SeamlessBio connects CROs, ATMP manufacturers, vaccine producers and research institutions in EU and UK with verified biological raw materials and supply chain solutions. Our portfolio covers:<\/p>\n<ul>\n<li><strong>FBS and bovine sera<\/strong> \u2014 multiple geographic origins, full traceability documentation, GMP-aligned<\/li>\n<li><strong>Human Serum<\/strong> \u2014 Standard, Type AB, Male, OTC, Delipidated, Heat-Inactivated and more; xeno-free for ATMP and clinical applications<\/li>\n<li><strong>BSA and HSA<\/strong> \u2014 for cell culture, diagnostic and pharmaceutical applications<\/li>\n<li><strong>Single-Use Bioprocess Bags and Tankliner<\/strong> \u2014 for scale-up and manufacturing operations<\/li>\n<li><strong>Cell4Pharma DMPK Assay Kits<\/strong> \u2014 for early drug metabolism and pharmacokinetics screening at CROs<\/li>\n<\/ul>\n<p>We are not a catalogue supplier. We source, verify and qualify \u2014 and we connect the right partners to the right buyers, with the documentation your procurement process requires.<\/p>\n<h2>Serum-Free Media in Vaccine and ATMP Manufacturing<\/h2>\n<p>For vaccine production in Vero, MDCK, HEK293 and CHO cells \u2014 and for ATMP manufacturing using T cells, MSCs and iPSC-derived products \u2014 serum-free and chemically defined media are increasingly the expected standard, not an upgrade. The regulatory case is clear: fewer adventitious agent risks, cleaner validation dossiers, and better batch-to-batch consistency.<\/p>\n<table>\n<thead>\n<tr>\n<th>Cell Line<\/th>\n<th>Application<\/th>\n<th>Serum-Free Advantage<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Vero<\/td>\n<td>Polio, rabies, influenza, COVID-19<\/td>\n<td>Eliminates bovine-derived risk; cleaner downstream processing<\/td>\n<\/tr>\n<tr>\n<td>MDCK<\/td>\n<td>Influenza vaccines<\/td>\n<td>Defined proliferation kinetics; consistent viral yield<\/td>\n<\/tr>\n<tr>\n<td>HEK293<\/td>\n<td>Adenoviral vectors, AAV, lentiviral vectors<\/td>\n<td>Near-mandatory for gene therapy vectors<\/td>\n<\/tr>\n<tr>\n<td>CHO<\/td>\n<td>VLP-based vaccines, recombinant antigens<\/td>\n<td>Established serum-free platforms; regulatory precedent<\/td>\n<\/tr>\n<tr>\n<td>T cells \/ MSCs<\/td>\n<td>CAR-T, MSC therapy, iPSC products<\/td>\n<td>Xeno-free required; eliminates immunogenicity risk<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"qa\">\n<div class=\"q\">Will SeamlessBio be at CPHI Milan 2026?<\/div>\n<div class=\"a\">Yes \u2014 Pascal Zimmermann from SeamlessBio will be at CPHI Worldwide 2026 in Milan from October 6\u20138 at Hall 12, Stand F75. Contact info@seamlessbio.de to schedule a meeting in advance.<\/div>\n<\/div>\n<div class=\"qa\">\n<div class=\"q\">How long will the FBS shortage last?<\/div>\n<div class=\"a\">Current market analysis indicates supply constraints will persist through at least 2028\u20132029. The US cattle herd requires three to five years to rebuild under favourable conditions. Strategic inventory management and supplier diversification are the most effective responses available right now.<\/div>\n<\/div>\n<div class=\"qa\">\n<div class=\"q\">Is Human Serum a viable replacement for FBS in ATMP manufacturing?<\/div>\n<div class=\"a\">For ATMP manufacturing, CAR-T expansion, MSC culture and clinical-grade applications, Human Serum AB is increasingly the preferred supplement. It is xeno-free, more physiologically relevant for human cell work, and better aligned with EMA and FDA expectations. For many ATMP applications, switching from FBS to Human Serum is a quality upgrade, not just a contingency measure.<\/div>\n<\/div>\n<div class=\"qa\">\n<div class=\"q\">What documentation does SeamlessBio provide for biological raw materials?<\/div>\n<div class=\"a\">We provide full traceability documentation including certificate of analysis, geographic origin testing, age verification, sterility and mycoplasma results, and chain-of-custody documentation. For GMP environments, we also supply pharmacopoeia compliance statements (EP\/USP) and viral safety documentation as required.<\/div>\n<\/div>\n<div class=\"qa\">\n<div class=\"q\">What is the difference between serum-free and chemically defined media?<\/div>\n<div class=\"a\">Serum-free media contains no animal serum but may still include undefined biological components such as hydrolysates. Chemically defined media has a fully known, specified composition with no undefined biological inputs \u2014 providing maximum batch-to-batch consistency and the cleanest regulatory documentation for GMP applications.<\/div>\n<\/div>\n<div class=\"cta\">\n<h3>Meet SeamlessBio at CPHI Milan \u2014 Hall 12, Stand F75<\/h3>\n<p>SeamlessBio connects European and UK biopharma manufacturers with GMP-grade biological raw materials. Find us at CPHI or reach out directly to discuss your supply strategy.<\/p>\n<div class=\"cta-btns\">\n<a href=\"https:\/\/seamlessbio.de\/contact\/\" class=\"btn\">Schedule a Meeting \u2192<\/a><br \/>\n<a href=\"https:\/\/seamlessbio.de\/human-serum\/\" class=\"btn-o\">Human Serum \u2192<\/a><br \/>\n<a href=\"https:\/\/seamlessbio.de\/fbs\/\" class=\"btn-o\">FBS &amp; Bovine Sera \u2192<\/a>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SeamlessBio is at CPHI Worldwide 2026 in Milan \u2014 Hall 12, F75. If you are dealing with FBS supply pressure, evaluating serum-free alternatives, or looking to qualify a backup supplier [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"categories":[46],"tags":[],"class_list":["post-3809","post","type-post","status-publish","format-standard","hentry","category-cell-culture"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CPHI 2026 Milan \u2014 SeamlessBio &amp; Serum-Free Media for Vaccine and Bioprocess Manufacturing<\/title>\n<meta name=\"description\" content=\"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CPHI 2026 Milan \u2014 SeamlessBio &amp; Serum-Free Media for Vaccine and Bioprocess Manufacturing\" \/>\n<meta property=\"og:description\" content=\"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-24T08:13:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T09:10:29+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":[\"Article\",\"BlogPosting\"],\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\"},\"headline\":\"CPHI 2026 Milan \u2014 SeamlessBio\",\"datePublished\":\"2026-09-24T08:13:37+00:00\",\"dateModified\":\"2026-09-24T09:10:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/\"},\"wordCount\":891,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"articleSection\":[\"Cell Culture\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/\",\"name\":\"CPHI 2026 Milan \u2014 SeamlessBio & Serum-Free Media for Vaccine and Bioprocess Manufacturing\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-09-24T08:13:37+00:00\",\"dateModified\":\"2026-09-24T09:10:29+00:00\",\"description\":\"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"Place\",\"ProfessionalService\"],\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#local-main-organization-logo\"},\"address\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#local-main-place-address\"},\"telephone\":[\"+49 (851) 37932226\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+49 (851) 37932226\",\"email\":\"info@seamlessbio.de\"},\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\"],\"opens\":\"09:00\",\"closes\":\"17:00\"},{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"00:00\"}],\"email\":\"info@seamlessbio.de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/seamlessbio.de\"],\"url\":\"https:\\\/\\\/seamlessbio.de\\\/de\\\/author\\\/admin\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#local-main-place-address\",\"streetAddress\":\"Dr.-Ernst-Derra-Str. 4\",\"addressLocality\":\"Passau\",\"postalCode\":\"94036\",\"addressRegion\":\"Bavaria\",\"addressCountry\":\"DE\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"width\":973,\"height\":288,\"caption\":\"SeamlessBio\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"Passau\" \/>\n<meta name=\"geo.region\" content=\"Deutschland\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CPHI 2026 Milan \u2014 SeamlessBio & Serum-Free Media for Vaccine and Bioprocess Manufacturing","description":"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/","og_locale":"de_DE","og_type":"article","og_title":"CPHI 2026 Milan \u2014 SeamlessBio & Serum-Free Media for Vaccine and Bioprocess Manufacturing","og_description":"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.","og_url":"https:\/\/seamlessbio.de\/de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/","og_site_name":"SeamlessBio","article_published_time":"2026-09-24T08:13:37+00:00","article_modified_time":"2026-09-24T09:10:29+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"admin","Gesch\u00e4tzte Lesezeit":"4\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":["Article","BlogPosting"],"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#article","isPartOf":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/"},"author":{"name":"admin","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529"},"headline":"CPHI 2026 Milan \u2014 SeamlessBio","datePublished":"2026-09-24T08:13:37+00:00","dateModified":"2026-09-24T09:10:29+00:00","mainEntityOfPage":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/"},"wordCount":891,"commentCount":0,"publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"articleSection":["Cell Culture"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/","url":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/","name":"CPHI 2026 Milan \u2014 SeamlessBio & Serum-Free Media for Vaccine and Bioprocess Manufacturing","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-09-24T08:13:37+00:00","dateModified":"2026-09-24T09:10:29+00:00","description":"SeamlessBio at CPHI Worldwide 2026 in Milan. Why serum-free cell culture media is becoming essential for vaccine, ATMP and biopharma manufacturing \u2014 and what we are bringing to Milan.","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/"]}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","Place","ProfessionalService"],"@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#local-main-organization-logo"},"image":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#local-main-organization-logo"},"address":{"@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#local-main-place-address"},"telephone":["+49 (851) 37932226"],"contactPoint":{"@type":"ContactPoint","telephone":"+49 (851) 37932226","email":"info@seamlessbio.de"},"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday"],"opens":"09:00","closes":"17:00"},{"@type":"OpeningHoursSpecification","dayOfWeek":["Saturday","Sunday"],"opens":"00:00","closes":"00:00"}],"email":"info@seamlessbio.de"},{"@type":"Person","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529","name":"admin","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/seamlessbio.de"],"url":"https:\/\/seamlessbio.de\/de\/author\/admin\/"},{"@type":"PostalAddress","@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#local-main-place-address","streetAddress":"Dr.-Ernst-Derra-Str. 4","addressLocality":"Passau","postalCode":"94036","addressRegion":"Bavaria","addressCountry":"DE"},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/cphi-2026-milan-serum-free-media-vaccine-manufacturing\/#local-main-organization-logo","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","width":973,"height":288,"caption":"SeamlessBio"}]},"geo.placename":"Passau","geo.region":"Deutschland"},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3809","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=3809"}],"version-history":[{"count":3,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3809\/revisions"}],"predecessor-version":[{"id":3812,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3809\/revisions\/3812"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=3809"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/categories?post=3809"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/tags?post=3809"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}